Pyxis Oncology, Inc. Insider Trading

PYXS

Last 12 months

Insiders sold 107K and bought nothing on the open market.

All of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in Nov 2024.

Net open-market

−107K

0 buys · 1 sale

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

0 / 1

executives and directors

Last open-market buy

Nov 2024

Nov 26, 2024

Get an email when PYXS's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 1	Gordonmd Global Investments LP Large holder	Bought	5,517,000	—	—	55%	Form 4
Jun 30	Jakob Dupont Director	Sold10b5-1 plan	35,000	$3.06	107K	47%	Form 4
Apr 14, 2025 – Apr 21, 2025	Rachel Humphrey Director	Sold10b5-1 plan 3 parts	15,496	$1.02 average	16K	16%	Form 4
Nov 26, 2024	Pamela Ann Connealy CFO & COO	Bought 2 parts	88,850	$1.96 average	174K	4.0%	Form 4

Oct 1
Gordonmd Global Investments LP
Large holder · bought 5,517,000
—
55% of stake
Jun 3010b5-1 plan
Jakob Dupont
Director · sold 35,000 at $3.06
107K
47% of stake
Apr 14, 2025 – Apr 21, 202510b5-1 plan
Rachel Humphrey
Director · sold 15,496 at avg $1.02
16K
16% of stake
Nov 26, 2024
Pamela Ann Connealy
CFO & COO · bought 88,850 at avg $1.96
174K
4.0% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch PYXS, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with PYXS

CompareIntrinsic value

CVSICV Sciences, Inc.

$0.01-1.00%25

KROSKeros Therapeutics Inc.

$10.83+0.00%20

NEUPNeuphoria Therapeutics Inc.

$2.98-0.33%10

EMMAEmmaus Life Sciences, Inc.

$0.03-17.50%21

IRDOpus Genetics Inc.

$4.27+8.65%10

CBIOCrescent Biopharma, Inc.

$13.42+2.76%50

BIOABioAge Labs, Inc.

$5.95-0.17%10

ZBIOZenas BioPharma, Inc.

$28.46+0.28%10

Held by ETFs

PYXS is in 4 US ETFs. The largest of them, with PYXS's weight in each:

Spot a number that looks wrong? Check it in PYXS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing PYXS

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.